Theratechnologies (TSE:TH) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Theratechnologies has resumed production of its EGRIFTA SV® following a temporary shutdown to address FDA inspection observations. The company is managing its inventory to meet demand and is working closely with the FDA to ensure a smooth release of new batches. This development is crucial for maintaining the supply of EGRIFTA SV® in the U.S. market.
For further insights into TSE:TH stock, check out TipRanks’ Stock Analysis page.